2026 Vol.44, N°8 - Table of contents
August - Scleroderma 2026
One year in review
CER20154
2026,44,8
Pg. 1453-1467
Free to view
Systemic sclerosis: one year in review 2026
G. Lepri, M. Di Battista, V. Codullo, G. Ghezzi, L.M. Bianchessi, F. Liuzzi, S. Guiducci, A. Della Rossa
DOI: https://doi.org/10.55563/clinexprheumatol/j7bbx5
G. Lepri, M. Di Battista, V. Codullo, G. Ghezzi, L.M. Bianchessi, F. Liuzzi, S. Guiducci, A. Della Rossa
DOI: https://doi.org/10.55563/clinexprheumatol/j7bbx5
Full Papers
CER18920
2026,44,8
Pg. 1468-1474
Free to view
Effectiveness of SARS-CoV-2 vaccination program in systemic sclerosis patients treated by autologous haematopoietic stem cell transplantation: a comparative study on behalf of MATHEC-SFGM-TC group
L. Biard, G. Pugnet, C. Cacciatore, P.H. Prata, B. Crichi, F. Urbain, I. Munia, P. Lansiaux, C. Le Maignan, D. Farge
DOI: https://doi.org/10.55563/clinexprheumatol/8o94lv
L. Biard, G. Pugnet, C. Cacciatore, P.H. Prata, B. Crichi, F. Urbain, I. Munia, P. Lansiaux, C. Le Maignan, D. Farge
DOI: https://doi.org/10.55563/clinexprheumatol/8o94lv
CER19107
2026,44,8
Pg. 1475-1482
Free to view
Clinical practice guidelines for reporting nailfold videocapillaroscopy: a Delphi consensus on behalf of the Italian Society of Rheumatology Study Group on Capillaroscopy
F. Ingegnoli, D. Pireddu, E. Platania, R. De Angelis, A. Alunno, A. Ariani, S. Barsotti, V. Batani, L. Belloli, A. Bezzi, S.L. Bosello, F. Cacciapaglia, S.L. Calvisi, N. Carlo-Stella, F. Carubbi, I. Cavazzana, V. Codullo, M. Colaci, M. Cornalba, G. Cuomo, G. De Marchi, A. Della Rossa, M. Di Battista, E. Di Ruscio, P. Faggioli, M. Favero, R. Foti, F. Girelli, D. Giuggioli, S. Guiducci, E. Gotelli, V. Grosso, E. Hysa, A. Iuliano, F. Lalli, L. Leveghi, E. Marasco, G. Mennillo, G. Moroncini, G. Pellegrino, C. Perricone, C. Pizzorni, E. Praino, L. Quarta, V.L. Ramoni, L. Santo, C. Schenone, M. Sebastiani, L. Serafino, T. Serban, P. Stobbione, A. Sulli, S. Truglia, V. Smith, M. Cutolo, V. Riccieri
On behalf of the Study Group on Capillaroscopy and Microcirculation in Rheumatic Diseases of the Italian Society of Rheumatology (CAPSIR)
DOI: https://doi.org/10.55563/clinexprheumatol/2z4j95
F. Ingegnoli, D. Pireddu, E. Platania, R. De Angelis, A. Alunno, A. Ariani, S. Barsotti, V. Batani, L. Belloli, A. Bezzi, S.L. Bosello, F. Cacciapaglia, S.L. Calvisi, N. Carlo-Stella, F. Carubbi, I. Cavazzana, V. Codullo, M. Colaci, M. Cornalba, G. Cuomo, G. De Marchi, A. Della Rossa, M. Di Battista, E. Di Ruscio, P. Faggioli, M. Favero, R. Foti, F. Girelli, D. Giuggioli, S. Guiducci, E. Gotelli, V. Grosso, E. Hysa, A. Iuliano, F. Lalli, L. Leveghi, E. Marasco, G. Mennillo, G. Moroncini, G. Pellegrino, C. Perricone, C. Pizzorni, E. Praino, L. Quarta, V.L. Ramoni, L. Santo, C. Schenone, M. Sebastiani, L. Serafino, T. Serban, P. Stobbione, A. Sulli, S. Truglia, V. Smith, M. Cutolo, V. Riccieri
On behalf of the Study Group on Capillaroscopy and Microcirculation in Rheumatic Diseases of the Italian Society of Rheumatology (CAPSIR)
DOI: https://doi.org/10.55563/clinexprheumatol/2z4j95
CER18959
2026,44,8
Pg. 1483-1491
Free to view
Risk of major cardiovascular events in patients with systemic sclerosis: insights into an underestimated concern from a systematic literature review and meta-analysis
G. Pellegrino, D. Mohammad Reza Beigi, A. Varvaro, M. Arese, V. Riccieri, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/6pstix
G. Pellegrino, D. Mohammad Reza Beigi, A. Varvaro, M. Arese, V. Riccieri, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/6pstix
CER19237
2026,44,8
Pg. 1492-1497
Free to view
Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation
P. Kaenmuang, N.R. Goldman, A. Srirangan, F. Danzo, W.-H. Yip, A. Taki, S. Boreland, B. Vitri, C.J. Stock, C.P. Denton, A.U. Wells, V.H. Ong, P. Sestini, E.A. Renzoni
DOI: https://doi.org/10.55563/clinexprheumatol/dvur8b
P. Kaenmuang, N.R. Goldman, A. Srirangan, F. Danzo, W.-H. Yip, A. Taki, S. Boreland, B. Vitri, C.J. Stock, C.P. Denton, A.U. Wells, V.H. Ong, P. Sestini, E.A. Renzoni
DOI: https://doi.org/10.55563/clinexprheumatol/dvur8b
CER19316
2026,44,8
Pg. 1498-1505
Free to view
Multiparametric assessment of sarcopenia in systemic sclerosis: prognostic implications and interplay with malnutrition
M. Di Battista, A. Rossi, G. Pisano, G. Ghezzi, E. Bertolucci, A. Della Rossa, M. Mosca
DOI: https://doi.org/10.55563/clinexprheumatol/aa6fl3
M. Di Battista, A. Rossi, G. Pisano, G. Ghezzi, E. Bertolucci, A. Della Rossa, M. Mosca
DOI: https://doi.org/10.55563/clinexprheumatol/aa6fl3
CER19515
2026,44,8
Pg. 1506-1513
Free to view
Evaluation of particle-based multi-analyte technology for autoantibody detection in systemic sclerosis: concordance with conventional methods and clinical associations
A. Pérez-Isidro, G.-M. Lledó-Ibañez, S. Prieto-González, F. Hernández-González, C. Andalucia, M.A. Aure, C. Melus, N. De Moner, O. Viñas, G. Espinosa, E. Ruiz-Ortiz
DOI: https://doi.org/10.55563/clinexprheumatol/pfen40
A. Pérez-Isidro, G.-M. Lledó-Ibañez, S. Prieto-González, F. Hernández-González, C. Andalucia, M.A. Aure, C. Melus, N. De Moner, O. Viñas, G. Espinosa, E. Ruiz-Ortiz
DOI: https://doi.org/10.55563/clinexprheumatol/pfen40
CER19213
2026,44,8
Pg. 1514-1523
Free to view
BLyS/APRIL dual inhibition for systemic sclerosis: a single-centre, single-arm, open-label clinical trial of telitacicept
Q. Shi, J. Zhang, Q. Yu, Y. Gu, J. Liu, F. Wang, S. Wang, B. Liu, L. Chen, Q. Lu, X. Lin, J. Ding, H. Dong
DOI: https://doi.org/10.55563/clinexprheumatol/jckjcq
Q. Shi, J. Zhang, Q. Yu, Y. Gu, J. Liu, F. Wang, S. Wang, B. Liu, L. Chen, Q. Lu, X. Lin, J. Ding, H. Dong
DOI: https://doi.org/10.55563/clinexprheumatol/jckjcq
CER19371
2026,44,8
Pg. 1524-1533
Free to view
Hand bone densitometry associates with nailfold capillaroscopic severity of microvascular damage in systemic sclerosis: a pilot study
S. Paolino, R. Campitiello, A. Casabella, E. Gotelli, E. Hysa, C. Pizzorni, G. Davoli, E. Caratto, A. Sulli, V. Smith, M. Cutolo
DOI: https://doi.org/10.55563/clinexprheumatol/zr2o21
S. Paolino, R. Campitiello, A. Casabella, E. Gotelli, E. Hysa, C. Pizzorni, G. Davoli, E. Caratto, A. Sulli, V. Smith, M. Cutolo
DOI: https://doi.org/10.55563/clinexprheumatol/zr2o21
CER19628
2026,44,8
Pg. 1534-1542
Free to view
Prevention and management of gastrointestinal side effects in patients with systemic sclerosis-interstitial lung disease receiving anti-fibrotic therapy: a modified Delphi consensus study
N. Del Papa, P. Cipriani, C. Galeone, P. Mariani, C. Ogliari
Collaborator/s: P. Airò, L. Beretta, S.L. Bosello, C. Campochiaro, I. Cavazzana, V. Codullo, L. Dardani, R. De Angelis, G. De Luca, M. De Santis, A. Della Rossa, M.G. Lazzaroni, L. Magnani, M. Orlandi, A. Spinella, B. Vigone, E. Zanatta, G. Zanframundo
SSc-ILD Study Group
DOI: https://doi.org/10.55563/clinexprheumatol/rlzpfe
N. Del Papa, P. Cipriani, C. Galeone, P. Mariani, C. Ogliari
Collaborator/s: P. Airò, L. Beretta, S.L. Bosello, C. Campochiaro, I. Cavazzana, V. Codullo, L. Dardani, R. De Angelis, G. De Luca, M. De Santis, A. Della Rossa, M.G. Lazzaroni, L. Magnani, M. Orlandi, A. Spinella, B. Vigone, E. Zanatta, G. Zanframundo
SSc-ILD Study Group
DOI: https://doi.org/10.55563/clinexprheumatol/rlzpfe
CER19665
2026,44,8
Pg. 1543-1550
Free to view
Phosphodiesterase-5 inhibitors, but not calcium channel blockers, improve peripheral vascular function in systemic sclerosis
D.R. Machin, J. Tucker, S. Bloom, D.W. Wray, A.J. Donato, T.M. Frech
DOI: https://doi.org/10.55563/clinexprheumatol/tlicso
D.R. Machin, J. Tucker, S. Bloom, D.W. Wray, A.J. Donato, T.M. Frech
DOI: https://doi.org/10.55563/clinexprheumatol/tlicso
CER19565
2026,44,8
Pg. 1551-1561
Free to view
Development of the Fatigue Coping Strategies Questionnaire: a Scleroderma Patient-Centred Intervention Network (SPIN) Cohort Cross-Sectional Study
C. Dal Santo, M. Golberg, M.-E. Carrier, D. Harel, L. Kwakkenbos, S.J. Bartlett, C. Fortuné, A. Gietzen, K. Gottesman, G. Guillot, A. Lawrie-Jones, M. Richard, M. Sauvé, L. Mouthon, V.L. Malcarne, B.D. Thombs
Scleroderma Patient-centred Intervention Network Investigators
DOI: https://doi.org/10.55563/clinexprheumatol/m4a8ni
C. Dal Santo, M. Golberg, M.-E. Carrier, D. Harel, L. Kwakkenbos, S.J. Bartlett, C. Fortuné, A. Gietzen, K. Gottesman, G. Guillot, A. Lawrie-Jones, M. Richard, M. Sauvé, L. Mouthon, V.L. Malcarne, B.D. Thombs
Scleroderma Patient-centred Intervention Network Investigators
DOI: https://doi.org/10.55563/clinexprheumatol/m4a8ni
CER19600
2026,44,8
Pg. 1562-1569
Free to view
Clinical distinctions of anti-topoisomerase positive limited cutaneous systemic sclerosis in early disease: results from the early Systemic sclerOsis Longitudinal Assessment Registry from Turkey
M.E. Yayla, B. Okyar, E.D. Ersözlü, D.S. Özgür, C. Bes, A. Çefle, B. Firlatan Yazgan, G. Kimyon, T.M. Turgay, M.A. Baltaci, A. Avanoglu Guler, I. Vasi, A. Erden, R. Bilici, B. Sulu, G. Varkal, D. Arslan, Z. Uğurlu, A. Doğru, A. Avcu, F. Alibaz-Oner, B. Yurttaş, S.C. Güven, Ş. Erten, O. Küçükşahin, T. Kahraman Denizhan, S. Şenel, G. Yamancan, A. Karatas, E. Genç, M.E. Tezcan, Ö. Dogan Agbuga, S. Amikishiyev, A. Babayigit, A. Şahin, R. Yildirim, T. Kaşifoğlu, B. Aslan, T.S. Öğüt, O. Zengin, F. Albayrak, E. Er Gülbezer, V. Yazısız, M. Birlik, G. Hatemi, Y. Yalçınkaya, M. Inanç, S.S. Koca, D. Temiz Karadağ, M. Erdogan, A. Sarı, A. Akdogan
DOI: https://doi.org/10.55563/clinexprheumatol/lh87cq
M.E. Yayla, B. Okyar, E.D. Ersözlü, D.S. Özgür, C. Bes, A. Çefle, B. Firlatan Yazgan, G. Kimyon, T.M. Turgay, M.A. Baltaci, A. Avanoglu Guler, I. Vasi, A. Erden, R. Bilici, B. Sulu, G. Varkal, D. Arslan, Z. Uğurlu, A. Doğru, A. Avcu, F. Alibaz-Oner, B. Yurttaş, S.C. Güven, Ş. Erten, O. Küçükşahin, T. Kahraman Denizhan, S. Şenel, G. Yamancan, A. Karatas, E. Genç, M.E. Tezcan, Ö. Dogan Agbuga, S. Amikishiyev, A. Babayigit, A. Şahin, R. Yildirim, T. Kaşifoğlu, B. Aslan, T.S. Öğüt, O. Zengin, F. Albayrak, E. Er Gülbezer, V. Yazısız, M. Birlik, G. Hatemi, Y. Yalçınkaya, M. Inanç, S.S. Koca, D. Temiz Karadağ, M. Erdogan, A. Sarı, A. Akdogan
DOI: https://doi.org/10.55563/clinexprheumatol/lh87cq
CER19647
2026,44,8
Pg. 1570-1581
Free to view
Lung cancer risk in systemic sclerosis: data from an inception cohort and meta-analysis of published studies
A. Makris, V. Poulia, V.K. Bournia, K. Fragiadaki, M.G. Tektonidou, P.P. Sfikakis, S. Panopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/by5ndi
A. Makris, V. Poulia, V.K. Bournia, K. Fragiadaki, M.G. Tektonidou, P.P. Sfikakis, S. Panopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/by5ndi
CER19658
2026,44,8
Pg. 1582-1589
Free to view
Clinical characteristics, predictors and prognosis of systemic sclerosis with scleroderma renal crisis and pulmonary arterial hypertension
Z. Xu, J. Li, Y. Hou
DOI: https://doi.org/10.55563/clinexprheumatol/jr0zl5
Z. Xu, J. Li, Y. Hou
DOI: https://doi.org/10.55563/clinexprheumatol/jr0zl5
CER19952
2026,44,8
Pg. 1590-1595
Free to view
Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy
M. Di Battista, C. Romei, S. Barsotti, A. Marcucci, V. Uggenti, G. Ghezzi, A. Delle Sedie, A. Della Rossa, E. Neri, M. Mosca
DOI: https://doi.org/10.55563/clinexprheumatol/utoe2k
M. Di Battista, C. Romei, S. Barsotti, A. Marcucci, V. Uggenti, G. Ghezzi, A. Delle Sedie, A. Della Rossa, E. Neri, M. Mosca
DOI: https://doi.org/10.55563/clinexprheumatol/utoe2k
CER19991
2026,44,8
Pg. 1596-1605
Free to view
Association of circulating miR-29b with microvascular dysfunction and digital ulcers in patients with systemic sclerosis: a single-centre pilot study
F. Tambaro, C. Pellicano, A. Gigante, C. Gallicchio, E. Rosato, M. Muscaritoli
DOI: https://doi.org/10.55563/clinexprheumatol/733qf8
F. Tambaro, C. Pellicano, A. Gigante, C. Gallicchio, E. Rosato, M. Muscaritoli
DOI: https://doi.org/10.55563/clinexprheumatol/733qf8
CER20036
2026,44,8
Pg. 1606-1613
Free to view
Biochemical, radiological and histological effects of ixekizumab on skin tissue in a bleomycin-induced systemic sclerosis mouse model
G. Sargin, Y.B. Turgut, B. Yilmaz, G. Tuzcu, E. Eroğlu, A. Tuzcu, Y. Uyanikgil
DOI: https://doi.org/10.55563/clinexprheumatol/gruvgq
G. Sargin, Y.B. Turgut, B. Yilmaz, G. Tuzcu, E. Eroğlu, A. Tuzcu, Y. Uyanikgil
DOI: https://doi.org/10.55563/clinexprheumatol/gruvgq
Review
CER19481
2026,44,8
Pg. 1614-1625
Free to view
Macrophage heterogeneity governs the balance between fibrosis and tissue protection in systemic sclerosis
P. Zheng, C. Liu, X. Zhou, J. Lu, M. Li, L. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/kfkfod
P. Zheng, C. Liu, X. Zhou, J. Lu, M. Li, L. Zhu
DOI: https://doi.org/10.55563/clinexprheumatol/kfkfod
Paediatric Rheumatology - Special Articles
CER20447
2026,44,8
Pg. 1626
Free to view
Special articles. Outcome measures in juvenile systemic sclerosis: an unmet need. Introduction
N. Vasquez-Canizares, F. Zulian
DOI: https://doi.org/10.55563/clinexprheumatol/yg98sn
N. Vasquez-Canizares, F. Zulian
DOI: https://doi.org/10.55563/clinexprheumatol/yg98sn
CER20331
2026,44,8
Pg. 1627-1634
Free to view
Juvenile- and adult-onset systemic sclerosis: similarities and differences in early disease patterns: a scoping review
N. Vasquez-Canizares, M. Twilt, Q. Mccormick, P. Bhave, I.A. Dobre, S.C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/l4cx23
N. Vasquez-Canizares, M. Twilt, Q. Mccormick, P. Bhave, I.A. Dobre, S.C. Li
DOI: https://doi.org/10.55563/clinexprheumatol/l4cx23
CER20307
2026,44,8
Pg. 1635-1644
Free to view
Outcome measures for cutaneous and musculoskeletal involvement in juvenile systemic sclerosis: a scoping literature review
V. Maniscalco, M. Cakan, A. Robinson, N. Vasquez-Canizares, M. Lu, R. Zheng, A. Adrovic, B. Sozeri, S. Shenoi, S. Appenzeller, S. Sampath, M. Cattalini, M. Twilt, C.E. Pain, F. Zulian, S.C. Li
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative
DOI: https://doi.org/10.55563/clinexprheumatol/00khha
V. Maniscalco, M. Cakan, A. Robinson, N. Vasquez-Canizares, M. Lu, R. Zheng, A. Adrovic, B. Sozeri, S. Shenoi, S. Appenzeller, S. Sampath, M. Cattalini, M. Twilt, C.E. Pain, F. Zulian, S.C. Li
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative
DOI: https://doi.org/10.55563/clinexprheumatol/00khha
CER20283
2026,44,8
Pg. 1645-1652
Free to view
Domains and outcome measures for the assessment of digital vasculopathy and Raynaud's phenomenon in adult and juvenile systemic sclerosis: a scoping literature review
V. Maniscalco, N. Vasquez-Canizares, J. Lemon, L. Stead, V. Leone, K. Clarke, F. Zulian, S.C. Li, M. Twilt, A. Adrovic, S. Appenzeller, E. Marrani, M. Çakan, E. Del Giudice, M. Cattalini, F. Tirelli, L.A. Robinson, S. Sampath, G. Mastrangelo, G. Simonini, C.E. Pain
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma Working Group
DOI: https://doi.org/10.55563/clinexprheumatol/76mozn
V. Maniscalco, N. Vasquez-Canizares, J. Lemon, L. Stead, V. Leone, K. Clarke, F. Zulian, S.C. Li, M. Twilt, A. Adrovic, S. Appenzeller, E. Marrani, M. Çakan, E. Del Giudice, M. Cattalini, F. Tirelli, L.A. Robinson, S. Sampath, G. Mastrangelo, G. Simonini, C.E. Pain
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma Working Group
DOI: https://doi.org/10.55563/clinexprheumatol/76mozn
CER20309
2026,44,8
Pg. 1653-1661
Free to view
Domains and outcome measures for the assessment of cardiac involvement in juvenile systemic sclerosis: a scoping literature review
F. Tirelli, N. Vasquez-Canizares, E. Marrani, L.A. Robinson, M. Çakan, V. Maniscalco, A. Adrovic, S. Appenzeller, M. Cattalini, S. Sampath, S.C. Li, M. Twilt, C.E. Pain, B. Castaldi, F. Zulian
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma Working Group
DOI: https://doi.org/10.55563/clinexprheumatol/q8g25b
F. Tirelli, N. Vasquez-Canizares, E. Marrani, L.A. Robinson, M. Çakan, V. Maniscalco, A. Adrovic, S. Appenzeller, M. Cattalini, S. Sampath, S.C. Li, M. Twilt, C.E. Pain, B. Castaldi, F. Zulian
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative and the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scleroderma Working Group
DOI: https://doi.org/10.55563/clinexprheumatol/q8g25b
CER20305
2026,44,8
Pg. 1662-1669
Free to view
Outcome measures used to assess gastrointestinal tract involvement in adults and children with systemic sclerosis: a scoping review
L.A. Robinson, E. Willis, O. Kasapcopur, A. Gunalp, N. Vasquez-Canizares, M. Twilt, C.E. Pain, F. Zulian, S.C. Li, L. Ambartsumyan
Collaborator/s: M. Çakan, A. Adrovic, V. Maniscalco, F. Tirelli, S. Appenzeller, S. Ishaq
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the CARRA Juvenile Scleroderma Workgroup initiative
DOI: https://doi.org/10.55563/clinexprheumatol/j5ohku
L.A. Robinson, E. Willis, O. Kasapcopur, A. Gunalp, N. Vasquez-Canizares, M. Twilt, C.E. Pain, F. Zulian, S.C. Li, L. Ambartsumyan
Collaborator/s: M. Çakan, A. Adrovic, V. Maniscalco, F. Tirelli, S. Appenzeller, S. Ishaq
on behalf of the International Juvenile Systemic Sclerosis Outcome Group (IJOG) initiative, and the CARRA Juvenile Scleroderma Workgroup initiative
DOI: https://doi.org/10.55563/clinexprheumatol/j5ohku
CER20298
2026,44,8
Pg. 1670-1679
Free to view
Evaluation of the gastrointestinal tract in juvenile systemic sclerosis: the paediatric gastroenterologist perspective
A. Krasaelap, R.E. Borlack, J. Garcia-Marin, L.A. Robinson, E. Willis, S.C. Li, N. Vasquez-Canizares, O. Kasapcopur, A. Gunalp, L. Ambartsumyan
DOI: https://doi.org/10.55563/clinexprheumatol/vxx3sy
A. Krasaelap, R.E. Borlack, J. Garcia-Marin, L.A. Robinson, E. Willis, S.C. Li, N. Vasquez-Canizares, O. Kasapcopur, A. Gunalp, L. Ambartsumyan
DOI: https://doi.org/10.55563/clinexprheumatol/vxx3sy
Letters to the Editor
CER19089
2026,44,8
Pg. 1680-1681
Free to view
Temporomandibular joint involvement and reduced mouth opening in systemic sclerosis: a not interdependent relationship
M.A. Bagni, S. Guiducci, G. Lepri, S. Torracchi, P. Bernardini, D. Melchiorre
DOI: https://doi.org/10.55563/clinexprheumatol/xxr41b
M.A. Bagni, S. Guiducci, G. Lepri, S. Torracchi, P. Bernardini, D. Melchiorre
DOI: https://doi.org/10.55563/clinexprheumatol/xxr41b
CER19130
2026,44,8
Pg. 1682
Free to view
Comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
G. Chen, L.M. Zhang, Y. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/5ynhsh
G. Chen, L.M. Zhang, Y. Zhang
DOI: https://doi.org/10.55563/clinexprheumatol/5ynhsh
CER19189
2026,44,8
Pg. 1683
Free to view
Reply to the comments on: Increased serum soluble interleukin-2 receptor concentrations are linked to high-sensitivity troponin T and disease progression in systemic sclerosis
S. Klapa, L. Schumacher, P. Lamprecht
on behalf of all authors.
DOI: https://doi.org/10.55563/clinexprheumatol/eaaqk8
S. Klapa, L. Schumacher, P. Lamprecht
on behalf of all authors.
DOI: https://doi.org/10.55563/clinexprheumatol/eaaqk8
CER19475
2026,44,8
Pg. 1684-1685
Free to view
Cervical spinal calcinosis in systemic sclerosis presenting with foraminal stenosis, radiculopathy and vertebral artery displacement
C. Valera-Ribera, L. Montolio-Chiva, J.J. Alegre-Sancho
DOI: https://doi.org/10.55563/clinexprheumatol/bpp3v9
C. Valera-Ribera, L. Montolio-Chiva, J.J. Alegre-Sancho
DOI: https://doi.org/10.55563/clinexprheumatol/bpp3v9
CER19791
2026,44,8
Pg. 1686
Free to view
Transient effect of iloprost on left ventricular global longitudinal strain in systemic sclerosis
C. Salmeri, I. Isaia, P. Fiorenza, L. Malatino, M. Colaci
DOI: https://doi.org/10.55563/clinexprheumatol/xiamb3
C. Salmeri, I. Isaia, P. Fiorenza, L. Malatino, M. Colaci
DOI: https://doi.org/10.55563/clinexprheumatol/xiamb3
CER19783
2026,44,8
Pg. 1687-1688
Free to view
Ultrastructural alterations in the bronchial mucosa of patients with early interstitial lung disease associated with systemic sclerosis
M. Wildt, O. Gustafsson, L. Bjermer, G. Westergren-Thorsson, K. Andréasson
DOI: https://doi.org/10.55563/clinexprheumatol/znpjtk
M. Wildt, O. Gustafsson, L. Bjermer, G. Westergren-Thorsson, K. Andréasson
DOI: https://doi.org/10.55563/clinexprheumatol/znpjtk
CER20084
2026,44,8
Pg. 1689-1690
Free to view
Obinutuzumab in a patient with overlap syndrome of systemic sclerosis and myositis with perimyocarditis and renal crisis
L. Schneider, A.-C. Pecher, D. Zinsser, J. Henes
DOI: https://doi.org/10.55563/clinexprheumatol/sdv6lb
L. Schneider, A.-C. Pecher, D. Zinsser, J. Henes
DOI: https://doi.org/10.55563/clinexprheumatol/sdv6lb